Genoptix, HistoRx sales and marketing update

Genoptix launched NexCourse BCa by AQUA technology in the U.S. The tests are for confirmatory estrogen receptor, progesterone receptor, and EGF receptor 2 ( HER2; ErbB2; neu) status prior to hormonal or antibody-based therapy or chemotherapy when initial results are inconclusive or negative. ...